Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT07739459

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Chu Lyon-Sud Lyon, Pierre Bénite, France

Ch Victor Dupouy Argenteuil, France

Ch D'Avignon - Hopital Henri Duffaut Avignon, France

Ch de La Cote Basque Bayonne, France

View all 17 locations

View Trial Details

Not Yet Recruiting

Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

NCT07738887

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Gent Ghent, Belgium

HELORA - Hôpital de La Louvière Site Jolimont La Louvière, Belgium

U.Z. LEUVEN - Campus GASTHUISBERG Leuven, Belgium

View all 29 locations

View Trial Details

Not Yet Recruiting

Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days.

NCT07739849

Conditions: Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study Of KITE-753 in R/R B-Cell ALL

NCT07674823

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

NCT07551583

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

NCT07072585

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

NCT07735533

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

NCT07731789

Conditions: Classic Follicular Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease

NCT07686770

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Kawasaki Disease, +7 more
Locations: Jiangxi Provincial Children's Hospital Nanchang, Jiangxi, China

Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

NCT07729397

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Diffuse Large B-Cell Lymphoma (DLBCL), +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions